Clinical Trial Update: HeartLinc, a Study With AMI Patients Undergoing PCI

View source ↗

Summary

HeartLinc, a clinical trial in acute myocardial infarction patients undergoing PCI, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Firalis SA | Conditions: AMI Patients | Status: COMPLETED